News
Posted
All
| 2019 | 2018 | 2017 | 2016
There are 3 new funding opportunity announcements about the Pre-Cancer Atlas associated with the Beau Biden Cancer MoonshotSM Initiative that are intended to accelerate cancer research. The purpose of the FOAs is to... Read More
POSTED: 10/23/2017SOURCE: DCP News
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of digital mammography for breast cancer screening, is now open for enrollment. TMIST researchers are enrolling... Read More
POSTED: 09/26/2017SOURCE: NCI Press Release
The third year of NCI’s Community Oncology Research Program (NCORP) was a charm as the community sites and research bases ramped up activities across the board, NCORP Director Worta McCaskill-Stevens, MD, told the network’... Read More
POSTED: 09/15/2017SOURCE: DCP News
Heart Attack, Stroke Risk May Be Elevated Following Cancer Diagnosis
A diagnosis of cancer can come with an increased risk of a heart attack or stroke in the months following the diagnosis, findings from a new study suggest. Within 6 months of a cancer diagnosis, in fact, the risk of having... Read More
POSTED: 08/25/2017SOURCE: NCI Cancer Currents Blog
Volume 8, Issue 3 Dear Colleague, The summer issue of Nutrition Frontiers showcases insulin-like growth factor and vitamin D in prostate cancer risk, bile acid and FXR inactivation and gender dissimilarity, and CerS6, a... Read More
POSTED: 08/09/2017SOURCE: DCP News
Tackling Cancer Health Disparities: Small Steps, Big Hopes
Several studies have documented that African American men are far more likely than non-Hispanic white men to die of prostate cancer. Other studies have shown that Hispanic women are more likely to be diagnosed with cervical... Read More
POSTED: 07/24/2017SOURCE: NCI Cancer Health Disparities Research News
Biomarker Test Could Reduce Unnecessary Biopsies to Detect Prostate Cancer
Testing for two biomarkers in urine may help some men avoid having to undergo an unnecessary biopsy to detect a suspected prostate cancer, findings from a new study show. Read More
POSTED: 06/09/2017SOURCE: NCI Cancer Currents Blog
As the NCI Cancer Prevention Fellowship Program (CPFP) celebrates its 30th anniversary, the successful cycle continues with the call for applications for the next class of fellows, who would start in 2018. The current... Read More
POSTED: 05/23/2017SOURCE: DCP News
Volume 8, Issue 2 Dear Colleague, The spring issue of Nutrition Frontiers showcases the calcium/magnesium intake ratio in colorectal adenoma, the role of PPARγ in metabolism and reproduction, and the effects of time-... Read More
POSTED: 05/10/2017SOURCE: DCP News
The Breast and Gynecologic Cancer Research Group (BGCRG), Division of Cancer Prevention (DCP), National Cancer Institute (NCI), has an opening for an experienced Medical Officer. BGCRG focuses on fostering the development... Read More
POSTED: 04/12/2017SOURCE: DCP News
Volume 8, Issue 1 Dear Colleague, The winter issue of Nutrition Frontiers showcases gut permeability and calcium supplementation, potential chemopreventive effects of dietary DHM for lung tumorigenesis, and the role of... Read More
POSTED: 02/02/2017SOURCE: DCP News
Less-Frequent Zoledronic Acid Treatment Effective at Preventing Bone Metastasis Complications
In a clinical trial involving patients with metastatic cancer, administration of zoledronic acid every 12 weeks was as effective at preventing skeletal-related events caused by bone metastases as administration every 4 weeks... Read More
POSTED: 01/30/2017SOURCE: NCI Cancer Currents Blog
The third annual Data Science Bowl opened on January 12, 2017 with the goal of improving the detection accuracy of low-dose computed tomography (LDCT) lung cancer screening using data curated by NCI’s Division of Cancer... Read More
POSTED: 01/13/2017SOURCE: DCP News
For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain
A drug most commonly used to treat depression may also reduce joint pain in some women being treated for early-stage breast cancer, according to the results of a randomized clinical trial. Read More
POSTED: 01/04/2017SOURCE: NCI Cancer Currents Blog